For research use only
| Cat No. | ABC-SC0026T |
| Product Type | Human Mesenchymal Stem Cells |
| Cell Type | Mesenchymal Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Amyotrophic Lateral Sclerosis |
| Storage | Liquid Nitrogen |
HighQC™ Human Bone Marrow MSCs from ALS Patients provide a human disease model for neuromuscular degeneration and stem cell–based intervention studies.
HighQC™ Human Bone Marrow Derived Mesenchymal Stem Cells (BM-MSCs) / Amyotrophic Lateral Sclerosis (ALS) Patient are multipotent stem cells isolated from the bone marrow of a clinically confirmed amyotrophic lateral sclerosis (ALS) donor. They exhibit fibroblast-like, spindle-shaped morphology and demonstrate no chromosomal abnormalities. The cells express high levels of mesenchymal surface markers, including CD29, CD44, CD105 and CD90, and do not exhibit telomere shortening, indicating retained replicative potential. BM-MSCs derived from ALS patients maintain essential stem cell functions, including adherence, immune modulation, and multilineage differentiation capacity. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human Bone Marrow Derived Mesenchymal Stem Cell/ Amyotrophic Lateral Sclerosis Patient, Human BM-MSC-ALS, hBM-MSC-ALS, Human Bone Marrow MSC ALS |
| Species | Human |
| Cat.No | ABC-SC0026T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Mesenchymal Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Amyotrophic Lateral Sclerosis |
| Storage | Liquid Nitrogen |
| Product Type | Human Mesenchymal Stem Cells |
HighQC™ Human Bone Marrow Derived Mesenchymal Stem Cells / Amyotrophic Lateral Sclerosis Patient serve as a disease-relevant cellular model for investigating the role of stromal cells in neurodegenerative disorders, particularly ALS. These cells are utilized in translational studies to assess their immunomodulatory and neuroprotective potential. For example, concurrent intrathecal and intravenous administration of autologous BM-MSCs has demonstrated temporary stabilization of functional parameters. This approach supports neuroprotective mechanisms, aiding in the exploration of sustained research applications for ALS.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).